Raf-1 LE-siRNA

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRaf-1 LE-siRNA
Drug Alias NameNeoPhectin Raf-1 siRNAcationic liposome mediated siRNARaf-1 siRNA (NeoPharma)LErafsiRNAliposomal Raf-1 siRNA (NeoPharm)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionCyclin D1 inhibitorsC-Raf kinase inhibitors
TargetsCyclin D1C-Raf kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeopharm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeopharm
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A